Description

Overview

GHK-Cu 50mg is a synthetic copper-binding peptide widely referenced in scientific and preclinical literature for its role in peptide signaling and copper-dependent biological research pathways. This compound is supplied exclusively for examination within controlled laboratory and analytical research environments. Published research involving GHK-Cu peptides is limited to non-clinical and investigational settings that explore cellular communication mechanisms, peptide–metal interactions, and molecular signaling models. Within structured laboratory studies, researchers may investigate peptide binding behavior, gene expression signaling, and biochemical pathway activity associated with copper peptide complexes under controlled in vitro conditions and regulated experimental frameworks designed strictly for scientific analysis. All documented findings related to this peptide remain confined to investigational research contexts. No claims are made regarding therapeutic application, clinical relevance, physiological outcomes, or suitability for human or veterinary use.

Biochemical Characteristics

GHK-Cu 50mg is a synthetic copper-binding peptide referenced in scientific literature for its association with copper peptide signaling and cellular communication research pathways. All characterization of this material is performed exclusively through physicochemical analysis and controlled laboratory investigation. Biochemical evaluation of GHK-Cu typically includes peptide sequence confirmation, copper–peptide complex verification, purity assessment through analytical chromatography, molecular mass validation, and stability analysis under controlled research conditions. Within preclinical investigative frameworks, laboratory studies may examine peptide–metal binding interactions, structural stability, solution behavior following reconstitution, and intracellular signaling responses associated with copper-dependent biochemical pathways. These evaluations are conducted within structured in vitro experimentation and regulated research models designed strictly for scientific analysis.

Molecular Class: Copper-binding tripeptide complex

Peptide Length: Tripeptide (Glycyl-L-histidyl-L-lysine) complexed with copper

Purity: Research-grade, high-purity peptide material

Material State: Lyophilized peptide powder

Quantity: 50 mg per vial

Intended Use: Laboratory research only

Research Applications

Within scientific and preclinical literature, GHK-Cu 50mg is referenced as a copper-binding peptide investigated exclusively in controlled, non-clinical laboratory environments. Its use in research settings is limited to analytical characterization, peptide–metal interaction analysis, and cellular signaling pathway modeling conducted under structured experimental protocols. Molecular signaling investigations involving copper-dependent peptide communication pathways within cellular research systems Peptide–metal binding interaction studies examining the behavior of copper–peptide complexes in biochemical environments Intracellular signaling cascade analysis within experimental models exploring peptide-mediated regulatory mechanisms Stability profiling and structural integrity evaluation following peptide reconstitution and controlled storage conditions Comparative investigations analyzing copper-binding peptides within broader peptide signaling and molecular communication research frameworks Analytical benchmarking within peptide research workflows utilizing validated laboratory reference materials and chromatographic verification methods All referenced applications remain strictly confined to laboratory-based investigation and non-clinical experimental use. No claims are made regarding biological outcomes, therapeutic potential, clinical relevance, or applicability beyond structured research settings.

Pathway / Mechanistic Context

In experimental and preclinical research literature, GHK-Cu is referenced in relation to copper-binding peptide signaling frameworks and cellular communication pathways examined at molecular and biochemical interaction levels. These analyses are conducted exclusively within controlled laboratory environments to support structured investigation of peptide–metal complex dynamics, molecular interaction patterns, and downstream cellular signaling responses under defined experimental conditions. Scientific discussions involving GHK-Cu frequently explore the behavior of copper–peptide complexes within biochemical signaling models associated with cellular regulation and molecular communication systems. Mechanistic evaluations in laboratory contexts may include peptide–metal binding interaction analysis, intracellular signaling pathway observation, gene expression pattern assessment, and downstream regulatory pathway mapping within experimental cellular systems designed for controlled scientific investigation. All mechanistic interpretations are observational and exploratory in nature and remain strictly confined to non-clinical research environments. No representations extend beyond controlled experimental settings, and no claims are made regarding biological outcomes, clinical relevance, or applicability outside structured investigational use.

Preclinical Research Summary

Preclinical research literature references observational findings related to GHK-Cu derived from controlled experimental systems designed to evaluate copper–peptide interaction dynamics within non-clinical research frameworks. These investigations focus on laboratory-based examination of peptide structure confirmation, copper-binding behavior, molecular stability profiling, and signaling pathway analysis under defined analytical conditions. Exploratory studies describe evaluation within peptide signaling models and cellular communication systems studied in structured research environments. Additional laboratory analyses may examine peptide integrity under varied storage parameters, stability following reconstitution, interaction mapping between peptide and metal ions within biochemical frameworks, and downstream intracellular signaling observations within regulated in vitro and preclinical research settings. All documented observations remain confined to investigational, analytical, and preclinical laboratory contexts and are presented strictly for exploratory scientific research purposes. No findings suggest clinical relevance, therapeutic intent, physiological application, or suitability for human or veterinary use. All references are limited exclusively to controlled laboratory research environments.

Form & Analytical Testing

GHK-Cu 50mg is supplied as a research-grade copper peptide produced under controlled manufacturing standards designed to support batch consistency, identity verification, and high-purity specifications suitable for laboratory evaluation. The material is provided as a lyophilized peptide powder to support stable storage conditions and standardized preparation procedures within structured analytical and experimental research workflows. Material verification focuses on physicochemical characterization and quality parameters relevant to peptide structure and copper–peptide complex analysis. Analytical evaluation commonly includes peptide identity confirmation, purity assessment using validated chromatographic techniques such as high-performance liquid chromatography (HPLC), and batch reproducibility verification. Additional analytical methodologies may include mass spectrometry–based molecular mass confirmation, peptide–metal complex validation, and stability profiling under defined storage and handling conditions. All testing, validation, and quality control procedures are conducted exclusively to support material characterization within controlled, non-clinical laboratory research environments.

Referenced Citations

Pickart, L. (1973). A tripeptide from human serum that promotes growth of cultured cells. Nature. Pickart, L., & Margolina, A. (2018). Regenerative and Protective Actions of the GHK-Cu Peptide in Human Skin. BioMed Research International. Pickart, L. (2015). GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Tissue Repair. Journal of Biomaterials Science. Siméon, A., et al. (2000). Modulation of dermal fibroblast activity by the tripeptide-copper complex glycyl-L-histidyl-L-lysine (GHK-Cu). Journal of Investigative Dermatology. Zhang, H., et al. (2020). Glycyl-L-histidyl-L-lysine (GHK) and its copper complex in cellular injury and repair mechanisms. Frontiers in Neuroscience. Dou, Y., et al. (2020). The Potential of GHK as a Peptide Involved in Cellular Remodeling and Anti-Oxidative Mechanisms. International Journal of Molecular Sciences.

ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY. FOR RESEARCH USE ONLY (RUO). NOT FOR HUMAN OR VETERINARY USE.

RUO Disclaimer

All products offered on this website, including GHK-Cu 50mg, are supplied strictly for in vitro laboratory research purposes only. In vitro research refers to experimental procedures conducted outside of living organisms within controlled laboratory environments for analytical and investigational study. These materials are not classified as drugs, pharmaceuticals, dietary supplements, or medical products. They have not been reviewed, evaluated, or approved by the U.S. Food and Drug Administration (FDA) for the diagnosis, treatment, cure, or prevention of any disease or medical condition. Any use beyond structured laboratory research — including administration to humans or animals — is strictly prohibited. For Laboratory Research Use Only (RUO). Not for human use, medical use, diagnostic use, or veterinary use.